NovoCure Limited (NVCR)
NASDAQ: NVCR · Real-Time Price · USD
18.49
-0.06 (-0.32%)
Apr 25, 2025, 4:00 PM EDT - Market closed
NovoCure Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -164.19 | -168.63 | -207.04 | -92.53 | -58.35 | 19.81 | Upgrade
|
| Depreciation & Amortization | 10.38 | 9.87 | 9.7 | 9.57 | 9.17 | 7.75 | Upgrade
|
| Other Amortization | 5.14 | 5.14 | 4.59 | 4.35 | 4.42 | 5.91 | Upgrade
|
| Asset Writedown & Restructuring Costs | 3.23 | 1.16 | 0.49 | 0.96 | 0.65 | 0.43 | Upgrade
|
| Loss (Gain) From Sale of Investments | -28.27 | -28.27 | -26.4 | -4.83 | -0.24 | -1.25 | Upgrade
|
| Stock-Based Compensation | 155.5 | 160.04 | 115.61 | 106.96 | 94.9 | 75.72 | Upgrade
|
| Other Operating Activities | -7.85 | -2.02 | 0.07 | -5.47 | 3.14 | -0.7 | Upgrade
|
| Change in Accounts Receivable | -31.69 | -26.36 | 29.41 | 2.55 | 5.27 | -30.35 | Upgrade
|
| Change in Inventory | 3.28 | 2.57 | -8.92 | -4.34 | 2.48 | -2.94 | Upgrade
|
| Change in Accounts Payable | 20.93 | 19.11 | 14.87 | 14.26 | 27.78 | 25.47 | Upgrade
|
| Change in Other Net Operating Assets | 3.08 | 1.04 | -5.71 | -0.67 | -6.46 | -0.7 | Upgrade
|
| Operating Cash Flow | -30.46 | -26.37 | -73.34 | 30.79 | 82.76 | 99.15 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | -62.80% | -16.53% | 272.46% | Upgrade
|
| Capital Expenditures | -41.68 | -42.86 | -27.09 | -21.36 | -24.17 | -14.97 | Upgrade
|
| Investment in Securities | -351.25 | -97.39 | 211.24 | -118.6 | -120.66 | -457.88 | Upgrade
|
| Investing Cash Flow | -392.93 | -140.24 | 184.15 | -139.96 | -144.83 | -472.85 | Upgrade
|
| Long-Term Debt Issued | - | 96.92 | - | - | - | 558.44 | Upgrade
|
| Long-Term Debt Repaid | - | -12.91 | -0.01 | -0.03 | -0.03 | -150.03 | Upgrade
|
| Net Debt Issued (Repaid) | 84.01 | 84.01 | -0.01 | -0.03 | -0.03 | 408.41 | Upgrade
|
| Issuance of Common Stock | 11.34 | 6.31 | 15.8 | 15.52 | 25.73 | 31.8 | Upgrade
|
| Financing Cash Flow | 95.35 | 90.32 | 15.79 | 15.49 | 25.7 | 440.21 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.11 | -0.17 | 0.13 | -0.1 | -0.19 | 0.25 | Upgrade
|
| Net Cash Flow | -327.93 | -76.47 | 126.73 | -93.78 | -36.56 | 66.76 | Upgrade
|
| Free Cash Flow | -72.14 | -69.22 | -100.43 | 9.43 | 58.59 | 84.18 | Upgrade
|
| Free Cash Flow Growth | - | - | - | -83.90% | -30.40% | 421.72% | Upgrade
|
| Free Cash Flow Margin | -11.60% | -11.44% | -19.72% | 1.75% | 10.95% | 17.03% | Upgrade
|
| Free Cash Flow Per Share | -0.66 | -0.64 | -0.94 | 0.09 | 0.57 | 0.77 | Upgrade
|
| Cash Interest Paid | 10.36 | 7.71 | 0.01 | 0.04 | 0.1 | 8.69 | Upgrade
|
| Cash Income Tax Paid | 25.52 | 23.46 | 13.67 | 5.48 | 3.11 | -3.26 | Upgrade
|
| Levered Free Cash Flow | 16.94 | 9.29 | -1.98 | 51.76 | 104.89 | 66.98 | Upgrade
|
| Unlevered Free Cash Flow | 19.63 | 11.99 | -3.21 | 50.55 | 103.7 | 73.45 | Upgrade
|
| Change in Net Working Capital | 3.5 | 11.72 | -38.65 | -9.9 | -50.03 | 15.71 | Upgrade
|
Updated Apr 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.